Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1222702 | Journal of Pharmaceutical and Biomedical Analysis | 2011 | 6 Pages |
Abstract
Etimicin sulfate is a semi-synthetic aminoglycoside which is modified from gentamicin C1a, used as an antibiotic effective both to Gram-positive and Gram-negative bacteria infections. Ten impurities were detected in the bulk drug by LC-ELSD and LC-ESI-MSn. Weakly acidic cation exchange resin, CM-sephadex and silica gel column chromatography were used for the isolation of six impurities. Based on LC/ESI-MSn and NMR analysis, related impurities were characterized as gentamicin C1a (1), 1-N-ethyl garamine (2), 2â³-N-ethyl gentamicin C1a, or 6â³-N-ethyl gentamicin C1a (3), 1-N-ethyl-3â²-N-demethyl gentamicin C2b (4), 3-N-ethyl gentamicin C1a (5), 6â³-deamino-6â³-hydroxyl etimicin (6), 1,3-N, N-diethyl garamine (7), 1-N-ethyl gentamicin C2b (8), 2â³ or 6â³-N-ethyl etimicin (9), 1,3-N, N-diethyl gentamicin C1a (10). 10 is a new aminoglycoside, the 1H and 13C NMR data of compounds 5-7, 10 are first reported in the paper. The possible mechanism for the formation of impurities is also discussed.
Keywords
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Hao Wang, Zhijie Zhang, Fei Xiong, Lingyun Wu, Ping Li, Wencai Ye,